Dr. Kaveh N. Rezvan, DO

Dr. Rezvan practices at Paloma Medical Group Inc in San Juan Capistrano, California.

Dr. Rezvan's NPI, 1003140922, was assigned on September 24, 2009. Dr. Rezvan graduated from WesternU College of Osteopathic Medicine of the Pacific in 2008. Dr. Rezvan holds California license 20A10932.

Dr. Rezvan's primary practice is Paloma Medical Group Inc, at 30230 Rancho Viejo Rd, San Juan Capistrano, CA 92675 in Orange County. The practice phone is (949) 443-4303.

Dr. Rezvan's primary practice is Paloma Medical Group Inc in San Juan Capistrano, California. Dr. Rezvan is also affiliated with Hoag Hospital Newport Beach. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Rezvan to 5 more hospitals, 5 group practices and clinics, 5 medical groups and 3 skilled nursing facilities, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rezvan practices, 14 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Rezvan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Rezvan is board certified in sleep medicine by the American Board of Family Medicine. Dr. Rezvan is licensed in California.

Dmand AI lists acute sinusitis, asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia and pulmonary fibrosis among the conditions Dr. Rezvan treats.

CMS data shows 5,099 Medicare services from Dr. Rezvan across 27 procedure codes in 2024, for 547 Medicare patients. Medicare paid $544,093 for them.

CMS counts 547 Medicare patients who saw Dr. Rezvan in 2024. The largest group is 75 to 84, with 201 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rezvan's median patient age at 71, with 47% women.

In 2024, Dr. Rezvan wrote 3,853 Medicare Part D claims for 247 patients. 76% of them were for generic drugs. CMS names the drug for 3,277 of them, across 91 drugs with 11 or more claims each, at $424,208 in total drug cost. In 2023, CMS named 2,986 claims across 94 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Rezvan for performance year 2024, reported as part of a group. Dr. Rezvan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rezvan as offering telehealth.

CMS Open Payments shows 354 general payments to Dr. Rezvan from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $1,391.

Dr. Rezvan graduated from WesternU College of Osteopathic Medicine of the Pacific in 2008.

Dr. Rezvan is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.